Home / Medical/Health Care / Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen

Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen

– Company Has Produced More Than 400,000 Vaccine Regimens for Use in Large-Scale Clinical Trials by April 2015 NEW BRUNSWICK, New Jersey, Jan. 6, 2015 / PRNewswire - Johnson & Johnson (NYSE: JNJ) today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen […]

Comments are closed.

Scroll To Top